-
ConocoPhillips chief seeks extra US protection of Mideast assets
-
Oil prices jump as Trump's Iran claims raise doubts
-
In world first, antimatter taken on test drive at CERN
-
New Chile president withdraws support for Bachelet UN chief bid
-
Mammals cannot be cloned infinitely, mice study discovers
-
600-year-old pinot noir grape found in medieval French toilet
-
NASA to build $20 bn moon base, pause orbital lunar station plans
-
Czech 'arks' help preserve Ukraine's cultural heritage
-
Shiffrin closes on World Cup overall title with slalom win
-
Griezmann to leave Atletico for Orlando at end of season
-
New Nice mayor poses a 'real problem' for 2030 Winter Olympics
-
Afghanistan announces release of detained US citizen
-
Meta awaits verdict in New Mexico child safety trial
-
Pinheiro Braathen wins World Cup giant slalom title after Odermatt crashes
-
Aid flotilla arrives in Cuba as US oil blockade bites
-
Residents recount guilt, chaos in hearing on deadly Hong Kong fire
-
Oil prices jump, stocks slip as Trump's Iran claims raise doubts
-
World Snooker Championship to stay at Crucible
-
Mercedes new electric VLE: Price and performance?
-
Outlook worsens for whale stranded on German coast
-
Xiaomi quarterly profit slumps despite annual EV gains
-
Iran, Israel trade strikes despite Trump talk of negotiations
-
IPL's Bengaluru to keep 11 seats empty in honour of stampede dead
-
Oil prices jump, stocks waver after Trump's Iran claim
-
'A top person': Who is the US dealing with in Iran?
-
In Lebanon's Tyre, ancient site threatened by Israeli bombs
-
US-Israeli war on Iran is 'breach of international law': German president
-
Iran strikes Israel, denies Trump talks
-
Mbappe says injury is behind him, all systems go for World Cup
-
Supporters' group file lawsuit against 'excessive' World Cup ticket prices
-
Gas shortages push India's poor back to wood and coal
-
'Plundered': Senegal fishers feel sting of illegal, industrial vessels
-
Iran hits Israel with missiles after denying Trump talks
-
Stocks rise on Trump U-turn but unease sees oil bounce
-
Trans community alarmed as India moves to curb LGBTQ rights
-
Families' nightmare fight for justice in Austria child sex cases
-
Tiger Woods to return to action in TGL with Masters looming
-
Australia, EU agree sweeping new trade pact eight years in the works
-
Back to black: facing energy shock, Asia turns to coal
-
Iran fires new wave of missiles at Israel after denying Trump talks
-
Manila's jeepney drivers struggle as Mideast war sends diesel cost soaring
-
The contenders vying to be next Danish leader
-
India's historic haveli homes caught between revival and ruin
-
Denmark votes in close election, outgoing PM tipped to win
-
N. Korea's Kim vows 'irreversible' nuclear status, warns Seoul of 'merciless' response
-
Pressure on Italy as play-off hopefuls eye 2026 World Cup
-
Malinin and Sakamoto seek solace at figure skating worlds as Olympic champions absent
-
'Perfect Japan' posts spark Gen Z social media backlash
-
Asian stocks rise on Trump U-turn but unease sees oil bounce
-
Pistons halt Lakers streak while Spurs, Thunder win
Japan approves abortion pill for the first time
The abortion pill will become available in Japan for the first time after the health ministry approved the drug used to terminate early-stage pregnancy.
Abortion is legal in Japan up to 22 weeks but consent is usually required from a spouse or partner, and until now a surgical procedure had been the only option.
The ministry said in a notification to healthcare officials on Friday it had approved the drug made by British pharmaceutical company Linepharma.
The drugmaker filed its product, a two-step treatment of mifepristone and misoprostol, for approval in Japan in December 2021.
Similar medication is available in many countries including France, which first approved the abortion pill in 1988, and the United States, where it has been available since 2000.
The approval of the pill to end pregnancies up to nine weeks follows a ministry panel endorsement, which was postponed for a month as thousands of public opinions were submitted.
National broadcaster NHK said the total cost of the abortion pill and a medical consultation would be around 100,000 yen ($700). Abortions are not covered by public health insurance.
Surgical abortions can cost around 100,000 to 200,000 yen.
Mifepristone has been at the centre of a high-profile US court battle in recent weeks.
The US Supreme Court has temporarily preserved access to the widely used abortion drug, freezing rulings by lower courts that would have banned or severely restricted its availability.
Campaigners in Japan are also pushing for better access to the morning-after pill, which prevents pregnancy.
Emergency contraception cannot currently be bought in Japan without a doctor's approval. It is also the only medicine that must be taken in front of a pharmacist to stop it being sold on the black market.
N.Awad--SF-PST